PP
PDS Planning Portfolio holdings
AUM
$1.34B
This Quarter Return
+3.88%
1 Year Return
+14.79%
3 Year Return
+45.56%
5 Year Return
+81.82%
10 Year Return
–
AUM
$782M
AUM Growth
+$56.8M
(+7.8%)
Cap. Flow
+$33.4M
Cap. Flow
% of AUM
4.28%
Top 10 Holdings %
Top 10 Hldgs %
50.21%
Holding
354
New
49
Increased
204
Reduced
69
Closed
13
Top Buys
| 1 |
Vanguard Small-Cap Value ETF
VBR
|
$4.5M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$3.63M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$3.18M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
$3.17M |
| 5 |
iShares Global REIT ETF
REET
|
$2.7M |
Top Sells
| 1 |
Apple
AAPL
|
$11.5M |
| 2 |
AbbVie
ABBV
|
$1.74M |
| 3 |
Abbott
ABT
|
$1.11M |
| 4 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
$652K |
| 5 |
SPDR SSGA Global Allocation ETF
GAL
|
$463K |
Sector Composition
| 1 | Technology | 7.68% |
| 2 | Healthcare | 6.56% |
| 3 | Financials | 3.91% |
| 4 | Industrials | 2.54% |
| 5 | Consumer Discretionary | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Morgan Stanley
MS
$237B
| $445K | 0.06% |
5,210
+132
| +3% | +$11.3K |
|
152
iShares Gold Trust
IAU
$52.2B
| $439K | 0.06% |
12,050
+9
| +0.1% | +$328 |
|
153
Becton Dickinson
BDX
$54.3B
| $437K | 0.06% |
1,656
+123
| +8% | +$32.5K |
|
154
Amgen
AMGN
$153B
| $436K | 0.06% |
1,964
+293
| +18% | +$65.1K |
|
155
Intuitive Surgical
ISRG
$158B
| $431K | 0.06% |
1,261
+214
| +20% | +$73.2K |
|
156
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.28B
| $427K | 0.05% |
4,352
-123
| -3% | -$12.1K |
|
157
Toyota
TM
$252B
| $418K | 0.05% |
2,602
-695
| -21% | -$112K |
|
158
GE Aerospace
GE
$293B
| $416K | 0.05% |
4,740
+779
| +20% | +$68.3K |
|
159
Vanguard Growth ETF
VUG
$185B
| $412K | 0.05% |
1,456
+2
| +0.1% | +$566 |
|
160
Honeywell
HON
$136B
| $412K | 0.05% |
1,985
+26
| +1% | +$5.4K |
|
161
Charles Schwab
SCHW
$175B
| $410K | 0.05% |
7,226
+2,403
| +50% | +$136K |
|
162
3M
MMM
$81B
| $408K | 0.05% |
4,878
+822
| +20% | +$68.8K |
|
163
RTX Corp
RTX
$212B
| $408K | 0.05% |
4,164
+264
| +7% | +$25.9K |
|
164
Chubb
CB
$111B
| $405K | 0.05% |
2,104
+142
| +7% | +$27.3K |
|
165
Marsh & McLennan
MMC
$101B
| $405K | 0.05% |
2,153
+240
| +13% | +$45.1K |
|
166
Synopsys
SNPS
$110B
| $401K | 0.05% |
922
+179
| +24% | +$77.9K |
|
167
United Microelectronic
UMC
$16.7B
| $396K | 0.05% |
50,175
+883
| +2% | +$6.97K |
|
168
Lam Research
LRCX
$124B
| $392K | 0.05% |
6,090
+1,470
| +32% | +$94.5K |
|
169
Stryker
SYK
$149B
| $391K | 0.05% |
1,280
+70
| +6% | +$21.4K |
|
170
Equinix
EQIX
$74.6B
| $390K | 0.05% |
498
+96
| +24% | +$75.3K |
|
171
AT&T
T
$208B
| $384K | 0.05% |
24,069
-8,097
| -25% | -$129K |
|
172
Zoetis
ZTS
$67.6B
| $381K | 0.05% |
2,211
+739
| +50% | +$127K |
|
173
CME Group
CME
$97.1B
| $377K | 0.05% |
2,037
+103
| +5% | +$19.1K |
|
174
T-Mobile US
TMUS
$284B
| $373K | 0.05% |
2,686
+691
| +35% | +$96K |
|
175
Wells Fargo
WFC
$258B
| $371K | 0.05% |
8,700
+567
| +7% | +$24.2K |
|